Cargando…

5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway

Apolipoprotein E (apoE) is linked to the risk for Alzheimer’s disease (AD) and thus has been suggested to be an important therapeutic target. In our drug screening effort, we identified Ondansetron (OS), an FDA-approved 5-HT3 antagonist, as an apoE-modulating drug. OS at low micromolar concentration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinohara, Motoko, Shinohara, Mitsuru, Zhao, Jing, Fu, Yuan, Liu, Chia-Chen, Kanekiyo, Takahisa, Bu, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471172/ https://www.ncbi.nlm.nih.gov/pubmed/30934555 http://dx.doi.org/10.3390/ijms20061488

Ejemplares similares

Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013)

APOE2 is associated with longevity independent of Alzheimer’s disease
por: Shinohara, Mitsuru, et al.
Publicado: (2020)

Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan
por: Fu, Yuan, et al.
Publicado: (2016)

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
por: Li, Zonghua, et al.
Publicado: (2020)

ABCA7 and Pathogenic Pathways of Alzheimer’s Disease
por: Aikawa, Tomonori, et al.
Publicado: (2018)

ABCA7 Regulates Brain Fatty Acid Metabolism During LPS-Induced Acute Inflammation
por: Aikawa, Tomonori, et al.
Publicado: (2021)

ApoE and apoE receptors in brain lipid metabolism and AD
por: Bu, Guojun
Publicado: (2012)

LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL
por: Kurano, Makoto, et al.
Publicado: (2011)

Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
por: Yu, Xichao, et al.
Publicado: (2023)

Chronic Unpredictable Mild Stress Promotes Atherosclerosis via HMGB1/TLR4-Mediated Downregulation of PPARγ/LXRα/ABCA1 in ApoE(-/-) Mice
por: Gu, Hong-Feng, et al.
Publicado: (2019)

Generation and validation of APOE knockout human iPSC-derived cerebral organoids
por: Martens, Yuka A., et al.
Publicado: (2021)

Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells
por: Huang, Kun, et al.
Publicado: (2021)

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
por: Kanekiyo, Takahisa, et al.
Publicado: (2014)

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
por: Hu, Jin, et al.
Publicado: (2015)

LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2
por: Hussein, Maryem A., et al.
Publicado: (2015)

Curcumin promotes cholesterol efflux from brain through LXR/RXR-ABCA1-apoA1 pathway in chronic cerebral hypoperfusion aging-rats
por: Tian, Mingyuan, et al.
Publicado: (2012)

Compound K Attenuates the Development of Atherosclerosis in ApoE(−/−) Mice via LXRα Activation
por: Zhou, Li, et al.
Publicado: (2016)

Granisetron versus Ondansetron: Comparison of 5HT(3) antagonists in preventing spinal anaesthesia induced hemodynamic instability in obstetric patients
por: Wahid, Maheen, et al.
Publicado: (2022)

LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice
por: Hong, Cynthia, et al.
Publicado: (2012)

Expression of LXR-β, ABCA1 and ABCG1 in human triple-negative breast cancer tissues
por: Pan, Hailing, et al.
Publicado: (2019)

LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1
por: Patel, Deven, et al.
Publicado: (2019)

Sini Decoction Intervention on Atherosclerosis via PPARγ-LXRα-ABCA1 Pathway in Rabbits
por: Ju, Shicong, et al.
Publicado: (2018)

Moxibustion at CV4 alleviates atherosclerotic lesions through activation of the LXRα/ABCA1 pathway in apolipoprotein-E-deficient mice
por: Cui, Yingxue, et al.
Publicado: (2019)

LRP1 plays a major role in the amyloid-β clearance in microglia
por: N’Songo, Aurelie, et al.
Publicado: (2013)

Postoperative pharmacodynamic interaction of ondansetron; a 5-HT3 antagonist and paracetamol in patients operated in the ENT department under local anesthesia
por: Bhosale, Uma A., et al.
Publicado: (2014)

Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
por: Boehm-Cagan, Anat, et al.
Publicado: (2016)

Protective Effects of Platycodin D on Lipopolysaccharide-Induced Acute Lung Injury by Activating LXRα–ABCA1 Signaling Pathway
por: Hu, Xiaoyu, et al.
Publicado: (2017)

Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia
por: Kratzer, Adelheid, et al.
Publicado: (2009)

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
por: Raulin, Ana-Caroline, et al.
Publicado: (2022)

Oxidized LDL Downregulates ABCA1 Expression via MEK/ERK/LXR Pathway in INS-1 Cells
por: Lyu, Jingya, et al.
Publicado: (2021)

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease
por: Inoue, Yasuteru, et al.
Publicado: (2023)

Administration of Downstream ApoE Attenuates the Adverse Effect of Brain ABCA1 Deficiency on Stroke
por: Wang, Xiaohui, et al.
Publicado: (2018)

ABCA1/ApoE/HDL Signaling Pathway Facilitates Myelination and Oligodendrogenesis after Stroke
por: Li, Li, et al.
Publicado: (2020)

Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice
por: Liu, Jian, et al.
Publicado: (2018)

EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux
por: Nelson, Jessica Kristine, et al.
Publicado: (2017)

Hydroxytyrosol Reduces Foam Cell Formation and Endothelial Inflammation Regulating the PPARγ/LXRα/ABCA1 Pathway
por: Franceschelli, Sara, et al.
Publicado: (2023)

Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
por: Blower, P, et al.
Publicado: (2002)

Augmented Atherogenesis in LDL Receptor Deficient Mice Lacking Both Macrophage ABCA1 and ApoE
por: Lammers, Bart, et al.
Publicado: (2011)

Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
por: Wang, Na, et al.
Publicado: (2022)

Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1
por: Jia, Qingling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r5dha4dn44bssvh09qbupeje6t